Tag: Clinical Trials
Barriers Persist for Enrolling Women in Cardiology Clinical Trials
Eight barriers discussed include differential care, ageism, logistical barriers, lack of diversity in clinical trial leadership
Enrollment in Cancer Treatment Trials Largely Unchanged by Pandemic
However, there was a significant decrease in enrollment for cancer control and prevention trials
Report Questions Benefit of FDA Accelerated Approval Pathway
112 of the 253 authorized drugs have not been confirmed as clinically effective; 24 of these have been on market more than five years
Should Changes Made to Clinical Trials During Pandemic Be Kept?
Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19
WHO Calls for Global Registry of Human Genome Editing
Studies involving human genome editing should be made public, even though it would not necessarily stop unprincipled scientists
Socioeconomic Deprivation Linked to Worse Survival in Cancer Trials
Overall, progression-free, and cancer-specific survival worse for participants from areas with highest socioeconomic deprivation
Guidance Offered for Improving Diversity in Multiple Myeloma Trials
Ways to improve representation of African Americans in clinical trials could be extrapolated to other underrepresented groups
Globalization of Cancer Trials Tied to Lower Enrollment of Blacks
Significant inverse correlation identified between proportion of patients enrolled outside the U.S. and disparity score
NIH Halts Trial of Convalescent Plasma for Mild COVID-19
While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo
Racial/Ethnic Minorities Underrepresented in Vaccine Trials
In adult trials, White patients and women are overrepresented; White patients account for 77.9 percent of participants